Wockhardt received tentative approval for the Fexofenadine Hydrochloride
Wockhardt received tentative approval for the Abbreviated New Drug Application from the US FDA for the Fexofenadine Hydrochloride oral tablets in multiple strengths of 30 mg, 60 mg and 180 mg.
Wockhardt Ltd. Wednesday said it has launched its generic version of nicardipine injections -- used to treat blood pressure -- in the US